<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIMS: Because of the extremely low <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">neoplastic progression</z:e> rate in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, it is difficult to diagnose patients with concomitant <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> early in their disease course </plain></SENT>
<SENT sid="1" pm="."><plain>If biomarkers existed in <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophageal epithelium to identify patients with concomitant esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, potential applications would be far-reaching </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of the current study was to identify global gene expression patterns in <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal epithelium capable of revealing simultaneous esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, even located remotely in the esophagus </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Tissues comprised <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal epithelia from 9 patients with esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, 8 patients lacking esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> or Barrett's, and 6 patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> alone </plain></SENT>
<SENT sid="4" pm="."><plain>cDNA microarrays were performed, and pattern recognition in each of these subgroups was achieved using shrunken nearest centroid predictors </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Our method accurately discriminated <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal epithelia of 8/8 patients without esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> or <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and of 6/6 patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> alone from <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal epithelia of 9/9 patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and concomitant esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, we identified genes differentially expressed between the above subgroups </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, based on their corresponding <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal epithelia alone, our method accurately diagnosed patients who had concomitant esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: These global gene expression patterns, along with individual genes culled from them, represent potential biomarkers for the early diagnosis of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> from <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal epithelia </plain></SENT>
<SENT sid="9" pm="."><plain>Genes discovered in <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus that are differentially expressed in patients with vs. without esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> merit further pursuit in molecular genetic, functional, and therapeutic interventional studies </plain></SENT>
</text></document>